Dr. Michael Hausmann

Angestellt, Chief Technology Officer, Global Head of R&D and Program Management Office, AliveDx

Nyon, Schweiz

Über mich

Idea-to-Revenue Executive and Board member creating health care value through clinical & technology innovation. >25 years of industry, global leadership and product development experience with exposure to all aspects of accelerating profitable growth, building outstanding teams, strategic planning & execution, portfolio & program management, technology innovation, proteomics, biomarkers, assay & system development, intellectual property, licensing, partnerships, regulatory approvals, commercial launch, clinical demand generation, life cycle management, investor relations. Passionate about turning science & technology into solutions that make a difference for patients, clinicians & laboratories. Passionate about developing people, teams & partnerships with industry & academia. Passionate about turning organizations around for success and creating the future of diagnostic & life science businesses.

Fähigkeiten und Kenntnisse

Forschung und Entwicklung
Business Development
Projektmanagement
Produktentwicklung
Innovationsmanagement
Technologie
Unternehmensführung
Project Management Office
Strategische Planung
Start-up
Mergers & Acquisitions
Supervisory board

Werdegang

Berufserfahrung von Michael Hausmann

  • Bis heute 1 Jahr und 9 Monate, seit Sep. 2022

    Non-Executive Director (NED) and Member of the Supervisory Board

    Aidian Oy

    Member of the Board of Directors

  • Bis heute 2 Jahre und 10 Monate, seit Aug. 2021

    Chief Technology Officer, Global Head of R&D and Program Management Office

    AliveDx

    CTO and Head of research, development, technical support and program management, Member of the Executive Management team

  • 1 Jahr und 5 Monate, März 2020 - Juli 2021

    Member of the Test Evaluation Working Group

    International Federation of Clinical Chemistry (IFCC)

    Working Group Member

  • 5 Jahre und 1 Monat, Juli 2016 - Juli 2021

    Senior Director Global R&D - Clinical Diagnostics Division & BRAHMS Biomarker BU

    Thermo Fisher Scientific

    Head of R&D for Thermo Fisher Scientific's Clinical Diagnostic Division and for its BRAHMS Biomarker Business Unit

  • 5 Jahre, Apr. 2011 - März 2016

    Vice President R&D - Immunoassays

    bioMerieux

    Head of BioMerieux's global Immunoassay R&D Organization with groups in France, China and Brazil for research, biotechnology, design, development and life cycle management. Member of the Clinical Diagnostics and Immunoassay business unit leadership teams. Identification of new business opportunities. Advising bioMerieux and Merieux Development on licensing and investment. Automated, Point-of-Care, Lateral Flow, Bloodscreening and Next Generation Immunoassays.

  • 10 Monate, Juni 2010 - März 2011

    Senior Director R&D Clinical Applications

    bioMerieux
  • 7 Jahre und 3 Monate, Apr. 2003 - Juni 2010

    Director Research & Development and Project Management

    Abbott Laboratories

    Head of the Abbott Diagnostics R&D center in Germany; strategic planning of the R&D project portfolio; discovery, concepts, feasibility, development, clinical trials, transfers to European manufacturing sites & commercialization; co-development alliances; biomarker & companion diagnostics assessments; research collaborations with academia ; on-market product support; manufacturing process design; productivity & quality system improvements

  • 3 Jahre und 2 Monate, März 2000 - Apr. 2003

    Manufacturing Operations Process Team Manager

    Abbott Diagnostics

    Managing a cross-functional manufacturing, technical support, QA and customer complaint investigations team; strategic planning of multi-site manufacturing relocation programs; deputy site head of production (stellv. Herstellungsleiter)

  • 3 Jahre und 3 Monate, Jan. 1997 - März 2000

    Technical Leader

    Abbott Diagnostics

    Technical leadership and coordination of on-market product support; customer complaint investigations; productivity improvements; support of R&D, Operations and Quality System programs

  • 4 Monate, Sep. 1996 - Dez. 1996

    Post-Doc

    German Cancer Research Center (DKFZ)

    Post-doctoral fellowship, Immunogenetics (lab Peter Krammer): Apoptosis, Oncology, T Cell Immunology

Ausbildung von Michael Hausmann

  • 4 Monate, Juli 2015 - Okt. 2015

    General Management Program

    CEDEP, European Center of Executive Development, in association with INSEAD

    Leadership, Strategy, Finance, Innovation

  • 3 Jahre und 6 Monate, März 1993 - Aug. 1996

    Biology

    Max-Planck-Institute for Immunbiology, Freiburg

    Immunology, Apoptosis, Oncology, Cellular Biology

  • 7 Jahre und 8 Monate, Okt. 1985 - Mai 1993

    Chemistry

    Albert-Ludwigs-University, Freiburg & Johannes-Gutenberg University, Mainz

    Biochemistry

Sprachen

  • Deutsch

    Muttersprache

  • Englisch

    Fließend

  • Französisch

    Gut

21 Mio. XING Mitglieder, von A bis Z